Telangana DCA busts quack practicing allopathy without MBBS in Nagarkurnool

The DCA team seized nearly 20 varieties of medicines, including higher generation antibiotics, anti-ulcer drugs, analgesics etc, worth Rs 10,000, which were illegally stocked without a drug license for sale at the clinic

Hyderabad: The drug inspectors from Drugs Control Administration (DCA), Telangana raided the premises of a quack, Vasantpur Ravikumar, who was practicing allopathy without MBBS qualification in a clinic at Velgonda Village, Bijinapalle mandal, Nagarkurnool district.

During the course of the raids, the DCA team seized nearly 20 varieties of medicines, including higher generation antibiotics, anti-ulcer drugs, analgesics etc, worth Rs 10,000, which were illegally stocked without a drug license for sale at the clinic.

---

The raids were conducted by S. Viswanth Reddy, Drugs Inspector, Nagarkurnool and S. Vinay, Drugs Inspector, Narayanpet along with other officers.

The DG, TSDCA, V B Kamalasan Reddy wholesalers/dealers who supply medicines to such unqualified persons are also punishable under the Drugs and Cosmetics Act, and stringent action shall be taken against such Wholesalers/Dealers.

In another raid, the DCA teams have detected drugs falsely manufactured and sold under the guise of food products or nutraceuticals. The DCA teams detected Ferin-XT tablets (Ferrous Ascorbate, Folic Acid and Zinc Tablets) that were circulating in the market in Hyderabad. The tablets were falsely manufactured under a ‘food license (FSSAI license)’, DCA said.

The tablets were found to be illegally manufactured at Twins Pharma, S.V.Nagar, Mallapur, as a food product/nutraceutical. As per the label claim of the product, it is classified as a ‘drug’ according to the Drugs and Cosmetics Act.

The product ‘Ferin-XT Tablets’ must be manufactured only under a ‘drug license’ issued under the Drugs and Cosmetics Act, adhering strictly to the ‘Good Manufacturing Practices’ (GMP) outlined in Schedule-M of the Drugs Rules. Additionally, it must meet the quality standards prescribed in the ‘Indian Pharmacopoeia’ (IP) as mandated, DG, DCA, V B Kamalasan Reddy said.